QURE is a gene therapy company. It develops treatment for patients suffering from genetic and other devastating diseases.
The company just started clinical trials of a gene therapy for Huntington’s disease. If the gene therapy succeeds, it could mean a $7 billion annual market for QURE.
See chart and continue reading at STOCKNEWS.com